TEM
Tempus AI, Inc. · Healthcare · Health Information Services
$69.30
+1.43% today · +0.03% 1W
Oct 15 close or latest
ReadoutWhy it's moving
Moving with its group (XLV +2.6%)
- TEM +1.43% on the last session vs SPY +0.06%: +1.4 pts of stock-specific move.
- The health care ETF (XLV) +2.6% (+2.6 pts vs SPY): the stock moved with its group.
- 1 analyst action in the past 10 days (1 positive, 0 negative); latest: Canaccord Genuity maintained Buy, raised target $80.00 → $95.00.
- 6 insider or congressional trades in the past 30 days.
- Market backdrop (Today): Core PPI m/m 1.3% vs 0.3% expected (hotter); Core Retail Sales m/m 0.9% vs 0.6% expected (stronger); S&P futures -0.08%, 10-year yield -3bp in the 30 minutes after.
Assembled from Wallsti's own signals.
Activity & positioning
- Volume
- 1.1× its 20-day averagepace so far
- Short interest
- 24.9% of float · -15% vs prior report · 3.7 days to cover as of Sep 30
- Options volume
- —
- Implied volatility
- —
- Options-implied move
- —
Moved with
Health care ETF (XLV) +2.6% +2.6 pts vs SPY
Key facts
- Market cap
- $12.5B
- Held by institutions
- 59.7%
- 52-week range
- 40.77–97.31
- Analyst mean target
- $73.56
- Next earnings
- Nov 3 est.
- Forward P/E
- -8539.5
Recent events
Analyst ▲
Canaccord Genuity maintained Buy, raised target $80.00 → $95.00Analyst ▲
Guggenheim maintained Buy, raised target $65.00 → $92.00Insider ▼
Thomas Edward Schoenherr (CEO, Diagnostics) sold 10,281 shares ($873.9K) under a pre-arranged 10b5-1 plan 10b5-1 plan · filingInsider ▼
Eric P Lefkofsky (CEO and Chairman, Director, 10% owner) sold 250,000 shares ($19.4M) under a pre-arranged 10b5-1 plan 10b5-1 plan · filingAnalyst
Goldman Sachs started coverage at Neutral, target $75.00Insider ▼
Andrew Polovin (EVP, Chief Legal Officer) sold 2,951 shares ($221.3K) under a pre-arranged 10b5-1 plan 10b5-1 plan · filingInsider ▼
Ryan M Bartolucci (Chief Accounting Officer) sold 7,062 shares ($529.6K) under a pre-arranged 10b5-1 plan 10b5-1 plan · filingInsider ▼
Eric P Lefkofsky (CEO and Chairman, Director, 10% owner) sold 200,000 shares ($16.1M) under a pre-arranged 10b5-1 plan 10b5-1 plan · filingInsider ▼
Ryan Fukushima (CEO, Data) sold 700 shares ($49.0K) under a pre-arranged 10b5-1 plan 10b5-1 plan · filingAnalyst ▲
HC Wainwright & Co. maintained Buy, raised target $56.00 → $66.00Analyst
UBS started coverage at Neutral, target $70.00Analyst
Roth Capital started coverage at Neutral, target $67.00